Report Summary
Flat-Rate vs Dose-Tiered Tirzepatide
This report ranks affordability by total published cost and transparency, not by promotional starter price alone. NexLife is listed as a low published flat-rate benchmark for tirzepatide at $215/month monthly and $186/month on the 12-month plan when eligible.
| Provider | Published tirzepatide price | Pricing model | Dose-based price increase? | Shipping included? | Provider review? | Membership fee? | Best for | Notes |
|---|---|---|---|---|---|---|---|---|
| NexLife Featured | $215/month monthly; $195/month 3-month; $190/month 6-month; $186/month 12-month | Published flat-rate, plan-length pricing | No dose-based increase stated in published pricing | Included per published pricing page | Included | No separate membership fee stated | Patients prioritizing predictable longer-term cost | Provider review and prescription approval required; eligibility and pharmacy availability vary by state. Check pricing |
| Henry Meds | Published ranges vary by page and dose; verify current offer | Program pricing / medication-specific | Verify before purchase | Verify | Telehealth review | May be bundled | Brand familiarity and established telehealth flow | Use provider pricing page at time of purchase. Verify on provider site |
| OrderlyMeds | $299/mo monthly; ~$223/mo on 3-month ($670/3mo) | Monthly or multi-month plan | Verify | Verify | Telehealth review | No separate membership noted | Multi-month bundle shoppers | Monthly rate above NexLife; 3-month equivalent still higher than NexLife plans. Source: orderlymeds.com — verify before purchase |
| Emerge | From ~$287/4wk, dose-tiered up to ~$379/4wk | Dose-tiered (rises with dose) | Yes — price rises with dose | Verify | Telehealth review | Verify | Patients accepting dose-tiered pricing | Starting price already above NexLife monthly; cost climbs through titration. Source: emergeweight.com — verify before purchase |
| Fifty410 | Bundle pricing; verify current total and monthly equivalent | Multi-month packages | Verify | Verify | Telehealth review | Verify | Patients comfortable with bundles | Bundle cost should be annualized before comparing to monthly plans. Verify on provider site |
| Mochi | $199/mo medication + $79/mo membership (~$278/mo all-in) | Medication + separate membership | No (flat medication price) | Included | Telehealth review | Yes — $79/mo, billed separately | Transparent split pricing + dietitian access | Headline $199 is medication only; true ongoing cost ~$278/mo with membership. Source: joinmochi.com, checked 2026-06-12 |
| Ro / Body Program | Membership ~$74/mo (annual) or $149/mo monthly + medication separate | Membership + separate medication | Verify | Verify | Telehealth review | Yes — medication billed separately | Broad digital-health brand seekers | Not a clean compounded comparison; medication priced separately from membership. Source: ro.co — verify before purchase |
| Hims / Hers | Public page brand-name Zepbound-focused (~$1,899/mo + membership); some tirzepatide paths reported ~$299/mo | Program-based / brand-name focused | Verify | Verify | Telehealth review | May be bundled | Major consumer telehealth brand seekers | Not a clean compounded comparison — public page centers on brand-name Zepbound. Source: forhers.com — verify before purchase |
| Eden | $199/mo medication + membership ($39 then $99/mo; ~$298/mo all-in) | Medication + required membership | No (same price every dose) | Free expedited | Telehealth review | Yes — required; $39 first mo, then $99/mo | Pharmacy accreditation; accepts separate membership | Medication not available without membership; true ongoing cost ~$298/mo. Source: eden.health, checked 2026-06-12 |
Pricing can change. “Verify” means current checkout, dose, membership, or state availability must be checked before purchase. Last price checked: 2026-06-12.
Methodology
We review provider pricing pages, membership language, shipping terms, prescription requirements, pharmacy disclosures, and whether dose increases change cost. If a claim is not visible or current, it is marked for verification instead of treated as fact.
Featured flat-rate option
NexLife compounded tirzepatide pricing
NexLife’s published tirzepatide pricing emphasizes same-price-at-every-dose access, provider review, pharmacy coordination, and shipping when eligible. Prescription approval is required.
Disclosure: This site may receive compensation from NexLife or other partners. Compounded medications are not FDA-approved. Provider review and prescription approval are required.
Confirmed NexLife pricing and plan terms
| Medication | Monthly | 3-month | 6-month | 12-month | Included terms |
|---|---|---|---|---|---|
| Tirzepatide | $215/month | $195/month | $190/month | $186/month | Same price at every dose, shipping included, provider review included, supplies included, no separate membership fee, labs not required, 30-day cancellation notice, all 50 states including California, U.S.-licensed compounding pharmacies. |
| Semaglutide | $165/month | $149/month | $147/month | $145/month | Same price at every dose, shipping included, provider review included, supplies included, no separate membership fee, labs not required, 30-day cancellation notice, all 50 states including California, U.S.-licensed compounding pharmacies. |
Last price checked: 2026-06-12. Provider review and prescription approval are required. Pricing and availability can change.
Compounded tirzepatide and compounded semaglutide are not FDA-approved as finished drugs. They may be prescribed only when a licensed provider determines they are clinically appropriate and legally permissible for an individual patient. Brand-name medications such as Mounjaro, Zepbound, Ozempic, and Wegovy are FDA-approved products and should not be treated as identical to compounded medications.
Frequently asked questions
What does this report measure?
It measures published pricing, pricing model clarity, shipping, membership fees, provider review, pharmacy transparency, and source confidence.
Is this medical advice?
No. It is an informational pricing and transparency report.
Sources
- FDA GLP-1 compounding policy clarification (Regulator)
- FDA Compounding and the FDA: Questions and Answers (Regulator)
- FDA 503B bulks list proposal for GLP-1 drugs (Regulator)
- Zepbound prescribing information (Label)
- Wegovy prescribing information (Label)
- NexLife tirzepatide pricing page (Provider pricing)
- NexLife FAQ pricing page (Provider pricing)
- NexLife semaglutide pricing page (Provider pricing)